查看購物車
  • English
  • Japanese
  • Korean
中東和非洲體外診斷市場規模及預測（2021-2034年）、全球和區域佔有率、趨勢及成長機會分析報告範圍：按產品、技術、應用、可近性、最終用戶和地區分類
市場調查報告書
商品編碼
1997054

中東和非洲體外診斷市場規模及預測（2021-2034年）、全球和區域佔有率、趨勢及成長機會分析報告範圍：按產品、技術、應用、可近性、最終用戶和地區分類

Middle East & Africa In-Vitro Diagnostic Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Technology, Application, Usability, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 466 Pages | 訂單完成後即時交付

價格
根據我們最新發布的研究報告《中東和非洲體外診斷市場預測至2034年——區域分析——按產品、技術、應用、可及性、檢測施行地點、檢體和最終用戶分類》，該市場預計將從2025年的38.9億美元成長到2034年的72.4億美元，2026年至20347年的複合年成長率。中東和非洲體外診斷市場的成長歸因於慢性非傳染性疾病盛行率的上升、感染疾病負擔的持續加重、醫療保健系統的加強以及公共衛生監測系統的擴展。

各國政府和世界衛生組織已將加強檢測網路建設列為優先事項，以應對慢性病和感染疾病帶來的挑戰。非洲非傳染性疾病和公共衛生進展報告強調了早期診斷和綜合護理的重要性，並指出診斷檢測基礎設施和標準化檢測通訊協定對於實現疾病控制和預防目標至關重要。加強包括愛滋病毒、霍亂和可透過常規免疫接種預防的疾病在內的感染疾病監測系統，並依賴診斷檢測來制定公共衛生應對策略。根據世衛組織關於愛滋病毒/愛滋病的概況介紹，到2024年底，全球整體將有4080萬人感染愛滋病毒，但透過檢查室檢測進行診斷、治療和病毒載量控制的持續努力仍然是控制疫情的關鍵。正如世衛組織2023-2024年疫情報告所述，非洲和東地中海區域的多國霍亂集體爆發促使各國加大對檢測基礎設施、快速診斷檢測（RDT）和品質保證計劃的投資，以支持早期病例發現和應對計劃的製定。隨著醫療保健系統覆蓋範圍的擴大和監測手段的日益完善，常規檢測正在初級保健和國家疾病控制計劃中得到確立，從而推動了對各種體外診斷 (IVD) 產品的需求，從基礎臨床化學測試到先進的分子診斷。

中東和非洲的體外診斷市場分為沙烏地阿拉伯、南非、阿拉伯聯合大公國（阿拉伯聯合大公國）以及其他中東和非洲地區。根據國際糖尿病聯盟（IDF）預測，到2024年，阿拉伯聯合大公國約有20.7%的成年人（約127萬人）將患有糖尿病，如此高的全國盛行率使得定期進行血糖值及相關生物標記檢測變得尤為必要。很大一部分人口面臨著與糖尿病和肥胖相關的代謝和心血管併發症的風險，而超重等生活方式相關的風險因素也處於較高水平，這推動了對綜合檢測和監測的需求。政府衛生部門正積極應對，推行強而有力的「國家糖尿病前期和糖尿病篩檢宣傳活動」。在政府加速計畫的支持下，衛生和預防部（MoHAP）在一年內完成了超過15萬次篩檢，超額完成了早期發現目標，並強調了糖化血紅蛋白（HbA1c）和其他診斷檢測的廣泛應用。除了糖尿病管理外，預防性醫療保健路徑中還納入了感染疾病、心臟標幟物、癌症生物標記和遺傳性疾病的常規篩檢，這體現了早期診斷的策略轉變。因此，慢性病的高發生率、全國範圍內的系統性篩檢舉措以及分子診斷、即時檢測和自動化體外診斷平台的整合，正在推動體外診斷在阿拉伯聯合大公國所有臨床環境中得到更廣泛的應用。

根據南非統計局對2024年上半年的估計，南非約有800萬人感染愛滋病毒，全國感染率為12.7%，15至49歲成年人群的感染率為16.68%。愛滋病毒檢測、監測及相關體外診斷的需求依然強勁。世界衛生組織（世衛組織）報告稱，截至2023年，南非結核病發病率仍然很高，每10萬人中有427例，且超過一半的結核病患者同時感染了愛滋病毒，這進一步增加了對包括快速分子檢測和照護現場（ POC）在內的綜合感染疾病診斷的需求。

糖尿病和心血管疾病等慢性非傳染性疾病的發生率不斷上升。根據政府衛生數據，糖尿病仍然是主要死因之一，尤其是在女性族群中，其死亡比例還在增加。這些疾病帶來的沉重負擔推動了公共和私營部門對生化和分子診斷的需求成長。政府正優先考慮早期發現和預防，並致力於加強全國健康篩檢計畫和檢查室網路，以促進體外診斷（IVD）的應用。

聚合酶鍊式反應（PCR）、次世代定序和即時診斷等技術進步正被引入臨床實踐，提高了感染疾病和慢性病的診斷速度和準確性。全球診斷試劑製造商與當地醫療機構的合作，正在擴大南非民眾獲得針對其流行病學特點量身定做的先進體外診斷（IVD）平台的途徑。

因此，感染疾病和非感染疾病的高發生率、政府主導的篩檢措施以及先進檢測技術的引入是推動南非市場擴張的主要因素。

目錄

第1章執行摘要

  • 分析師市場展望
  • 市場吸引力

第2章：中東和非洲體外診斷試劑市場狀況

  • 價值鏈分析
    • 原料供應商/零件
    • 製造商/工藝/技術
    • 經銷概覽
  • 供應鏈分析
    • 製造商和供應商名單
    • 潛在客戶名單（最多 50 家公司）
  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的競爭
  • PEST分析
  • 進口分析—中國/歐洲
    • 進口分析—中國/歐洲
    • 出口分析——中國/歐洲
  • 人工智慧（AI）的影響
    • 人工智慧對體外診斷能力的變革
    • 區域趨勢和策略舉措
    • 體外診斷領域的新型人工智慧應用
    • 推動採用的主要因素
  • 產品和技術藍圖
    • 初始階段（2001-2010 年）：引入數位系統和核心檢查室技術。
    • 分子診斷的發展與轉型（2011-2020）：PCR、即時檢測、基因檢測
    • 數位化和人工智慧驅動的整合（2021-2026）：智慧互聯診斷
    • 展望（2027-2035）：精準醫療與人群規模診斷
  • 永續發展與ESG趨勢
    • 環境永續性：減少整個價值鏈對環境的影響。
    • 社會責任：提高機會平等、公平性和勞動包容性
    • 管治：透明度、報告與課責
    • 新主題和區域促進因素
  • 法律規範
  • 2024年平均售價
    • 按產品分類，2024 年
      • 試劑和試劑盒
      • 手動和低自動化設備
      • 半自動設備
      • 全自動設備
    • 按最終用戶分類，2024 年
      • 試劑和試劑盒
      • 手動和低自動化設備
      • 半自動設備
      • 全自動分析儀
  • 主要疾病的盛行率
  • 救贖方案
    • 正式還款政策－有限且分散
    • 公共保險覆蓋範圍－一般檢測服務（不限於特定檢測項目）
    • 私人保險－價格不等，具體價格因計劃而異
    • 衛生技術評估（HTA）－已引入但仍不成熟。
    • 公共部門的主流採購方式是基於競標的。
  • 十大品牌的生產和零售價格
  • 公司分析（按行業和競標方式）
    • 對企業的策略意義
  • 競標批准數據
  • 主要設備銷售量（2025年）

第3章 競爭情勢

  • 主要企業的基準
  • 主要企業分析－按業務板塊分類，2024 年
  • 市佔率分析（2025 年）－按主要企業分類（%）
    • 按主要企業分類，2024 年（%）
    • 按主要產品分類，2024 年（%）
      • 產品類型
      • 產品品牌
  • 市場集中度
  • 中東和非洲（MEA）體外診斷市場中的VOC回饋

第4章：中東和非洲體外診斷市場－主要產業趨勢

  • 市場促進因素
    • 慢性非傳染性疾病盛行率不斷上升
    • 感染疾病的持續負擔
    • 加強醫療衛生體系建設，擴大公共衛生監測體系。
  • 市場限制因素
    • 醫療基礎設施和診斷能力有限
    • 熟練醫護人員及實驗室專家短缺
    • 法規結構分散，高品質診斷手段取得有限。
  • 市場機遇
    • 測試網路的整合
    • HIV診斷
    • 瘧疾診斷
  • 未來趨勢
    • 擴大即時檢測的應用
    • 分子診斷與個人化醫療的發展
    • 診斷領域的數位化與人工智慧融合
  • 促進因素和抑制因素的影響

第5章：中東與非洲體外診斷市場－區域市場分析

  • 中東和非洲體外診斷市場概覽
  • 中東和非洲體外診斷市場銷售（2021-2034 年）
  • 中東和非洲體外診斷市場預測與分析。

第6章：中東和非洲體外診斷市場收入分析－依產品分類

  • 產品市場主要企業清單（以美元計）
    • 試劑和試劑盒
      • 試劑和試劑盒：中東和非洲體外診斷市場 - 銷售收入，2021-2034 年
    • 裝置
      • 設備：中東和非洲體外診斷市場 - 收入，2021-2034 年
    • 軟體和服務
      • 軟體與服務：中東和非洲體外診斷市場－收入，2021-2034年

第7章 中東和非洲體外診斷市場收入分析 - 技術

  • 科技市場主要企業名單（以美元計）
    • 免疫檢測或免疫化學
      • 免疫檢測或免疫化學：中東和非洲體外診斷市場 - 收入，2021-2034 年
    • 層析法
      • 層析法：中東和非洲體外診斷市場－收入，2021-2034年
    • 細胞分析
      • 細胞分析：中東和非洲體外診斷市場—收入，2021-2034年
    • 蛋白質體學或代謝體學
      • 蛋白質體學或代謝體學：中東和非洲體外診斷市場－收入，2021-2034年
    • 感測器技術
      • 感測器技術：中東和非洲體外診斷市場－收入，2021-2034年
    • 小型化系統
      • 微型化系統：中東和非洲體外診斷市場－收入，2021-2034年
    • 連接複用技術
      • 多重檢測技術：中東和非洲體外診斷市場－收入，2021-2034年
    • 光學檢測
      • 光學檢測：中東和非洲體外診斷市場－收入，2021-2034年
    • 電化學分析
      • 電化學分析：中東和非洲體外診斷市場－收入，2021-2034年
    • 分離技術
      • 分離技術：中東和非洲體外診斷市場－收入，2021-2034年
    • 分子診斷
      • 分子診斷：中東和非洲體外診斷市場－收入，2021-2034年
    • 分析化學
      • 分析化學：中東和非洲體外診斷市場－收入，2021-2034年
    • 分子擴增
      • 分子擴增：中東和非洲體外診斷市場－收入，2021-2034年
    • 分子基因體學
      • 分子基因體學：中東和非洲體外診斷市場－收入，2021-2034年
    • 高通量分子
      • 高通量分子診斷：中東和非洲體外診斷市場－收入，2021-2034年
    • 基因分析
      • 基因分析：中東和非洲體外診斷市場－收入，2021-2034年

第8章：中東和非洲體外診斷市場收入分析—應用

  • 按應用領域分類的各市場主要企業列表（單位：美元）
    • 感染疾病
      • 感染疾病：中東和非洲體外診斷市場－收入，2021-2034年
    • 腫瘤學
      • 腫瘤學：中東和非洲體外診斷市場 - 收入，2021-2034 年
    • 循環系統
      • 循環系統醫學：中東和非洲體外診斷市場－收入，2021-2034年
    • 腎臟病學
      • 腎臟病學：中東和非洲體外診斷市場－收入，2021-2034年
    • 糖尿病
      • 糖尿病：中東和非洲體外診斷市場－收入，2021-2034年
    • 遺傳性疾病
      • 遺傳疾病：中東和非洲體外診斷市場－收入，2021-2034年
    • 血型鑑定與檢測
      • 血型鑑定與檢測：中東和非洲體外診斷市場－收入，2021-2034年
    • 過敏診斷
      • 過敏診斷：中東和非洲體外診斷市場－收入，2021-2034年
    • 消化系統疾病
      • 消化系統疾病：中東和非洲體外診斷市場 - 銷售收入，2021-2034 年
    • 免疫系統疾病
      • 免疫系統疾病：中東和非洲體外診斷市場－收入，2021-2034年
    • 其他
      • 其他：中東和非洲體外診斷市場 - 銷售收入，2021-2034 年

第9章：中東和非洲體外診斷市場收入分析—可用性

  • 可用性市場主要企業列表（以美元計）
    • 免洗設備
      • 一次性醫療器材：中東和非洲體外診斷市場－收入，2021-2034年
    • 可重複使用設備
      • 可重複使用設備：中東和非洲體外診斷市場－收入，2021-2034年

第10章：中東和非洲體外診斷市場收入分析－檢測施行地點

  • 測試施行地點市場主要企業名單（美元計）
    • 臨床檢測
      • 臨床檢測：中東和非洲體外診斷市場－收入，2021-2034年
    • 即時檢測
      • 即時檢測：中東和非洲體外診斷市場－收入，2021-2034年

第11章 中東和非洲體外診斷市場收入分析 -檢體

  • 檢體市場主要企業名單（以美元計）
    • 血清和血漿
      • 血清和血漿：中東和非洲體外診斷市場 - 銷售收入，2021-2034 年
    • 唾液檢體
      • 唾液檢體：中東和非洲體外診斷市場－收入，2021-2034年
    • 尿液檢體
      • 尿液檢體：中東和非洲體外診斷市場－收入，2021-2034年
    • 其他
      • 其他：中東和非洲體外診斷市場 - 收入，2021-2034 年

第12章：中東與非洲體外診斷市場收入分析－終端用戶

  • 終端用戶市場主要企業列表（以美元計）
    • 醫院
      • 醫院：中東和非洲體外診斷市場 - 收入，2021-2034 年
    • 臨床檢查室
      • 臨床檢查室：中東和非洲體外診斷市場 - 銷售收入，2021-2034 年
    • 居家醫療
      • 居家醫療：中東和非洲體外診斷市場－收入，2021-2034年
    • 其他
      • 其他：中東和非洲體外診斷市場 - 收入，2021-2034 年

第13章：中東與非洲體外診斷市場－國別分析

    • 南非市場
      • 南非
    • 沙烏地阿拉伯市場
      • 沙烏地阿拉伯
    • 阿拉伯聯合大公國市場
      • UAE
    • 其他中東和非洲市場
      • 其他中東和非洲地區

第14章：中東和非洲體外診斷市場的產業趨勢

  • 全球前20強公司名單
  • 中東及非洲體外診斷市場20大主要終端用戶名單

第15章：中東和非洲體外診斷市場－主要企業概況

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Danaher Corp
  • Siemens AG
  • Becton Dickinson and Co
  • Sysmex Corp
  • Bio-Rad Laboratories Inc
  • bioMerieux SA
  • DiaSorin SpA
  • QuidelOrtho Corp
  • ARKRAY Inc
  • BioSystems
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Werfen SA
  • Diagnostica Stago, Inc

第16章附錄

Product Code: TIPRE00042235

According to our new research study on "Middle East & Africa in-vitro diagnostic market forecast to 2034 -Regional Analysis - by Product, Technology, Application, Usability, Site of Testing, Specimen, and End User," the market is anticipated to grow from US$ 3.89 billion in 2025 to US$ 7.24 billion by 2034; the market is expected to register a CAGR of 7.2% from 2026 to 2034. Middle East & Africa In-Vitro Diagnostic market growth is attributed to the rising prevalence of chronic noncommunicable diseases, persistent infectious disease burden, health system strengthening, and public health surveillance expansion.

Governments and international health agencies have prioritized strengthening laboratory networks to manage chronic and infectious disease challenges. PublicHO African Region's progress reporting on noncommunicable diseases and public health indicates strong emphasis on early diagnosis and integrated care, which requires laboratory diagnostic infrastructure and standardized testing protocols to reach targets for disease control and prevention. Enhanced surveillance systems for communicable diseases, including HIV, cholera, and routine vaccine-preventable diseases, rely on diagnostic testing to inform public health responses. According to the WHO HIV/AIDS fact sheet, while at the global level 40.8 million people were living with HIV at the end of 2024, continued efforts to diagnose, treat, and suppress viral load through laboratory testing remain central to controlling the epidemic. Multi-country outbreaks of cholera in Africa and the Eastern Mediterranean stimulate investment in laboratory preparedness, rapid diagnostic test (RDT) stockpiles, and quality assurance programs to support early case detection and response planning, as documented in WHO outbreak situation reports from 2023-2024. As health systems expand coverage and surveillance sophistication, routine lab testing becomes embedded in primary care and national disease programs, increasing demand for an array of IVD products from basic clinical chemistry to advanced molecular diagnostics.

Middle East & Africa In-Vitro Diagnostic market is categorized into the Saudi Arabia, South Africa, UAE, and the Rest of Middle East & Africa. According to the International Diabetes Federation, in 2024, approximately 20.7 % of UAE adults (nearly 1.27 million people) were living with diabetes, a persistently high national prevalence that necessitates regular blood glucose and related biomarker testing. Large segments of the population are at risk of metabolic and cardiovascular complications linked to diabetes and obesity, with lifestyle risk factors such as being overweight present at elevated levels, driving demand for panel testing and monitoring. Government health authorities have responded with robust National Prediabetes and Diabetes Screening campaigns. The Ministry of Health and Prevention (MoHAP) exceeded its early-detection target by conducting over 150,000 screening tests in a year under the Government Accelerators Programme, emphasizing widespread use of HbA1c and other diagnostic assays. In addition to diabetes efforts, routine screening for infectious diseases, cardiovascular markers, cancer biomarkers, and genetic conditions are integrated into preventive care pathways, reflecting a strategic shift toward early diagnosis. The combination of high chronic disease prevalence, structured national screening initiatives, and the integration of molecular, point-of-care, and automation-enabled IVD platforms is therefore driving heightened utilization of in-vitro diagnostics across clinical settings in the UAE.

According to 2024 mid-year estimates by Statistics South Africa, approximately 8.0 million people in South Africa are living with HIV, with 12.7 % overall national prevalence and 16.68 % among adults aged 15-49, maintaining significant demand for HIV testing, monitoring, and related IVD assays. According to the World Health Organization (WHO), South Africa continues to face a high tuberculosis incidence of 427 per 100,000 population in 2023, and over half of TB patients also have HIV, reinforcing the need for combined infectious disease diagnostics, including rapid molecular tests and point-of-care screening.

Chronic non-communicable diseases such as diabetes and cardiovascular conditions are increasing, with government health data indicating that diabetes remains one of the leading causes of death and has risen as a proportion of mortality, particularly among women. This combined disease burden expands demand for biochemical and molecular diagnostics across public and private sectors. The government has prioritized early detection and prevention, strengthening national health screening programs and laboratory networks that drive IVD utilization.

Technological advancements such as PCR, next-generation sequencing, and point-of-care diagnostics are being implemented in clinical settings, improving the speed and accuracy of diagnoses for infectious and chronic diseases alike. Partnerships between global diagnostic manufacturers and local healthcare institutions are enhancing access to modern IVD platforms tailored to South Africa's epidemiological profile.

Thus, the high prevalence of communicable and non-communicable diseases, government screening initiatives, and adoption of advanced testing technologies are key factors driving the market expansion in South Africa.

The US Food and Drug Administration, National Institute of Health, are among the primary and secondary sources referred to while preparing the Middle East & Africa in-vitro diagnostic market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. Middle East and Africa In-Vitro Diagnostic Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
    • 2.2.1 Raw Material Suppliers / Components
    • 2.2.2 Manufacturers/ Process / Technology
    • 2.2.3 Distribution Landscape
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
    • 2.4.1 Bargaining Power of Suppliers:
    • 2.4.2 Bargaining Power of Buyers:
    • 2.4.3 Threat of New Entrants:
    • 2.4.4 Threat of Substitutes:
    • 2.4.5 Competitive Rivalry:
  • 2.5 PEST Analysis
  • 2.6 Import Analysis- China/Europe
    • 2.6.1 Import Analysis- China/Europe
    • 2.6.2 Export Analysis- China/Europe
  • 2.7 Impact of Artificial Intelligence (AI)
    • 2.7.1 AI Transforming Diagnostic Capabilities in IVD
    • 2.7.2 Regional Focus & Strategic Initiatives
    • 2.7.3 Emerging AI Applications in IVD
    • 2.7.4 Key Drivers Behind Adoption
  • 2.8 Product or Technology Roadmap
    • 2.8.1 Early Phase (2001-2010): Digital Systems & Core Lab Technology Adoption
    • 2.8.2 Growth & Molecular Shift (2011-2020): PCR, POC & Genetic Testing
    • 2.8.3 Digital & AI-Enabled Integration (2021-2026): Smart, Connected Diagnostics
    • 2.8.4 Outlook (2027-2035): Precision Medicine & Population-Scale Diagnostics
  • 2.9 Sustainability and ESG Trends
    • 2.9.1 Environmental Sustainability: Reducing Impact Across the Value Chain
    • 2.9.2 Social Responsibility: Expanding Access, Equity & Workforce Inclusion
    • 2.9.3 Governance: Transparency, Reporting & Accountability
    • 2.9.4 Emerging Themes & Regional Drivers
  • 2.10 Regulatory Framework
  • 2.11 Average Selling Price, 2024
    • 2.11.1 By Products, 2024
      • 2.11.1.1 Reagents & Kits
      • 2.11.1.2 Manual & Low-Automation Instruments
      • 2.11.1.3 Semi-Automated Instruments
      • 2.11.1.4 Fully Automated Instruments
    • 2.11.2 By End Users, 2024
      • 2.11.2.1 Reagents & Kits
      • 2.11.2.2 Manual & Low-Automation Instruments
      • 2.11.2.3 Semi-Automated Instruments
      • 2.11.2.4 Fully Automated Instruments
  • 2.12 Prevalence of Key Disease Indications
  • 2.13 Reimbursement Scenarios
    • 2.13.1 Formal Reimbursement Policies - Limited & Fragmented
    • 2.13.2 Public Insurance Coverage - General Lab Services, Not Test-Specific
    • 2.13.3 Private Insurance - Variable & Plan-Dependent
    • 2.13.4 Health Technology Assessment (HTA) - Emerging but Immature
    • 2.13.5 Tender-Based Procurement - Dominant in Public Sector
  • 2.14 Manufacturing & Retail Pricing of Key 10 Brands
  • 2.15 Company Analysis, By Trade and Tender
    • 2.15.1 Strategic Implications for Companies
  • 2.16 Tender Certifications Data
  • 2.17 Sales Volume of Key Instruments, 2025

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Key Company Analysis- By Segments, 2024
  • 3.3 Market Share Analysis, 2025 - By Key Players (%)
    • 3.3.1 By Key Players, 2024 (%)
    • 3.3.2 By Key Products, 2024 (%)
      • 3.3.2.1 Product Category
      • 3.3.2.2 Product Brands
  • 3.4 Market Concentration
  • 3.5 VOC Feedback in MEA IVD Market

4. Middle East and Africa In-Vitro Diagnostic Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Chronic Noncommunicable Diseases
    • 4.1.2 Persistent Infectious Disease Burden
    • 4.1.3 Health System Strengthening and Public Health Surveillance Expansion
  • 4.2 Market Restraints
    • 4.2.1 Limited Healthcare Infrastructure and Diagnostic Capacity
    • 4.2.2 Shortage of Skilled Healthcare Workforce and Laboratory Professionals
    • 4.2.3 Fragmented Regulatory Frameworks and Limited Access to Quality Diagnostics
  • 4.3 Market Opportunities
    • 4.3.1 Integration of Laboratory Networks
    • 4.3.2 Diagnostics for HIV
    • 4.3.3 Malaria Diagnostics
  • 4.4 Future Trends
    • 4.4.1 Increasing Adoption of Point-of-Care Testing
    • 4.4.2 Growth in Molecular Diagnostics and Personalized Medicine
    • 4.4.3 Digitalization and AI Integration in Diagnostics
  • 4.5 Impact of Drivers and Restraints

5. Middle East and Africa In-Vitro Diagnostic Market - Region Market Analysis

  • 5.1 Middle East and Africa In-Vitro Diagnostic Market Overview
  • 5.2 Middle East and Africa In-Vitro Diagnostic Market Revenue (US$ Million), 2021-2034
  • 5.3 Middle East and Africa In-Vitro Diagnostic Market Forecast and Analysis

6. Middle East and Africa In-Vitro Diagnostic Market Revenue Analysis - Product

  • 6.1 List of Key Players in Product Market, (US$)
    • 6.1.1 Reagents and Kits
      • 6.1.1.1 Overview
      • 6.1.1.2 Reagents and Kits: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.2 Instruments
      • 6.1.2.1 Overview
      • 6.1.2.2 Instruments: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.2.2.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Instruments
          • 6.1.2.2.1.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Clinical Chemistry Analyzers
            • 6.1.2.2.1.1.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Automated Clinical Chemistry Analyzers
          • 6.1.2.2.1.2 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Immunoassay Instruments
            • 6.1.2.2.1.2.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by ELISA Systems
            • 6.1.2.2.1.2.2 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Fluorescent Immunoassay Analyzers
          • 6.1.2.2.1.3 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Hematology and Coagulation Analyzers
            • 6.1.2.2.1.3.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Blood Cell Morphology Analyzers
            • 6.1.2.2.1.3.2 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by ESR Analyzers
            • 6.1.2.2.1.3.3 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Coagulation Analyzers
          • 6.1.2.2.1.4 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Urinalysis Instruments
    • 6.1.3 Software and Services
      • 6.1.3.1 Overview
      • 6.1.3.2 Software and Services: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

7. Middle East and Africa In-Vitro Diagnostic Market Revenue Analysis -Technology

  • 7.1 List of Key Players in Technology Market, (US$)
    • 7.1.1 Immunoassay or Immunochemistry
      • 7.1.1.1 Overview
      • 7.1.1.2 Immunoassay or Immunochemistry: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Immunoassay or Immunochemistry
          • 7.1.1.2.1.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Enzyme-linked Immunosorbent Assay (ELISA)
            • 7.1.1.2.1.1.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Blood Banking ELISA
          • 7.1.1.2.1.2 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Fluorescent Immunoassay (FIA)
          • 7.1.1.2.1.3 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Latex Agglutination
          • 7.1.1.2.1.4 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Turbidimetry
    • 7.1.2 Immunochromatography
      • 7.1.2.1 Overview
      • 7.1.2.2 Immunochromatography: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.2.2.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Immunochromatography
    • 7.1.3 Cellular analysis
      • 7.1.3.1 Overview
      • 7.1.3.2 Cellular analysis: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.3.2.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Cellular Analysis
    • 7.1.4 Proteomic or metabolomic
      • 7.1.4.1 Overview
      • 7.1.4.2 Proteomic or metabolomic: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.5 Sensor technology
      • 7.1.5.1 Overview
      • 7.1.5.2 Sensor technology: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.5.2.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Sensor Technology
    • 7.1.6 Miniaturized systems
      • 7.1.6.1 Overview
      • 7.1.6.2 Miniaturized systems: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.7 Multiplex technology
      • 7.1.7.1 Overview
      • 7.1.7.2 Multiplex technology: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.8 Optical detection
      • 7.1.8.1 Overview
      • 7.1.8.2 Optical detection: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.9 Electrochemical analysis
      • 7.1.9.1 Overview
      • 7.1.9.2 Electrochemical analysis: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.10 Separation technology
      • 7.1.10.1 Overview
      • 7.1.10.2 Separation technology: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.10.2.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Separation Technology
    • 7.1.11 Molecular Diagnosis
      • 7.1.11.1 Overview
      • 7.1.11.2 Molecular Diagnosis: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.11.2.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Molecular Diagnosis
    • 7.1.12 Analytical Chemistry
      • 7.1.12.1 Overview
      • 7.1.12.2 Analytical chemistry: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.13 Molecular Amplification
      • 7.1.13.1 Overview
      • 7.1.13.2 Molecular amplification: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.14 Molecular Genomics
      • 7.1.14.1 Overview
      • 7.1.14.2 Molecular genomics: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.14.2.1 Middle East and Africa In-Vitro Diagnostic Market Forecasts and Analysis by Molecular Genomics
    • 7.1.15 High-throughput molecular
      • 7.1.15.1 Overview
      • 7.1.15.2 High-throughput molecular: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.16 Genetic Analysis
      • 7.1.16.1 Overview
      • 7.1.16.2 Genetic Analysis: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

8. Middle East and Africa In-Vitro Diagnostic Market Revenue Analysis -Application

  • 8.1 List of Key Players in Application Market, (US$)
    • 8.1.1 Infectious Diseases
      • 8.1.1.1 Overview
      • 8.1.1.2 Infectious Diseases: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.2 Oncology
      • 8.1.2.1 Overview
      • 8.1.2.2 Oncology: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.3 Cardiology
      • 8.1.3.1 Overview
      • 8.1.3.2 Cardiology: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.4 Nephrology
      • 8.1.4.1 Overview
      • 8.1.4.2 Nephrology: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.5 Diabetes
      • 8.1.5.1 Overview
      • 8.1.5.2 Diabetes: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.6 Genetic Diseases
      • 8.1.6.1 Overview
      • 8.1.6.2 Genetic Diseases: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.7 Blood Grouping and Testing
      • 8.1.7.1 Overview
      • 8.1.7.2 Blood Grouping and Testing: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.8 Allergy Diagnostics
      • 8.1.8.1 Overview
      • 8.1.8.2 Allergy Diagnostics: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.9 Gastrointestinal Diseases
      • 8.1.9.1 Overview
      • 8.1.9.2 Gastrointestinal Diseases: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.10 Immune System Disorders
      • 8.1.10.1 Overview
      • 8.1.10.2 Immune System Disorders: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.11 Others
      • 8.1.11.1 Overview
      • 8.1.11.2 Others: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

9. Middle East and Africa In-Vitro Diagnostic Market Revenue Analysis -Usability

  • 9.1 List of Key Players in Usability Market, (US$)
    • 9.1.1 Disposable Devices
      • 9.1.1.1 Overview
      • 9.1.1.2 Disposable Devices: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 9.1.2 Reusable Equipment
      • 9.1.2.1 Overview
      • 9.1.2.2 Reusable Equipment: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

10. Middle East and Africa In-Vitro Diagnostic Market Revenue Analysis -Site of Testing

  • 10.1 List of Key Players in Site of Testing Market, (US$)
    • 10.1.1 Laboratory Tests
      • 10.1.1.1 Overview
      • 10.1.1.2 Laboratory Tests: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 10.1.2 Point of Care Tests
      • 10.1.2.1 Overview
      • 10.1.2.2 Point of Care Tests: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

11. Middle East and Africa In-Vitro Diagnostic Market Revenue Analysis -Specimen

  • 11.1 List of Key Players in Specimen Market, (US$)
    • 11.1.1 Blood Serum and Plasma
      • 11.1.1.1 Overview
      • 11.1.1.2 Blood Serum and Plasma: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.2 Saliva Specimens
      • 11.1.2.1 Overview
      • 11.1.2.2 Saliva Specimens: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.3 Urine Specimens
      • 11.1.3.1 Overview
      • 11.1.3.2 Urine Specimens: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.4 Others
      • 11.1.4.1 Overview
      • 11.1.4.2 Others: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

12. Middle East and Africa In-Vitro Diagnostic Market Revenue Analysis - End User

  • 12.1 List of Key Players in End User Market, (US$)
    • 12.1.1 Hospitals
      • 12.1.1.1 Overview
      • 12.1.1.2 Hospitals: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.2 Clinical Laboratories
      • 12.1.2.1 Overview
      • 12.1.2.2 Clinical Laboratories: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.3 Home Care
      • 12.1.3.1 Overview
      • 12.1.3.2 Home Care: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.4 Others
      • 12.1.4.1 Overview
      • 12.1.4.2 Others: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

13. Middle East and Africa In-Vitro Diagnostic Market - Country Analysis

  • 13.1 Middle East and Africa In-Vitro Diagnostic Market Breakdown by Countries
    • 13.1.1 South Africa Market
      • 13.1.1.1 South Africa: Middle East and Africa In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
      • 13.1.1.2 South Africa: Middle East and Africa In-Vitro Diagnostic Market- By Segmentation
        • 13.1.1.2.1 Product
          • 13.1.1.2.1.1 Instruments
            • 13.1.1.2.1.1.1 Clinical Chemistry Analyzers
            • 13.1.1.2.1.1.1.1 Automated Clinical Chemistry Analyzers
            • 13.1.1.2.1.1.2 Immunoassay Instruments
            • 13.1.1.2.1.1.2.1 ELISA Systems
            • 13.1.1.2.1.1.3 Fluorescent Immunoassay Analyzers
            • 13.1.1.2.1.1.4 Hematology And Coagulation Analyzers
            • 13.1.1.2.1.1.4.1 Blood Cell Morphology Analyzers
            • 13.1.1.2.1.1.4.2 ESR Analyzers
            • 13.1.1.2.1.1.4.3 Coagulation Analyzers
            • 13.1.1.2.1.1.5 Urinalysis Instruments
        • 13.1.1.2.2 Technology
          • 13.1.1.2.2.1 Immunoassay Or Immunochemistry
            • 13.1.1.2.2.1.1 Enzyme-linked Immunosorbent Assay (ELISA)
            • 13.1.1.2.2.1.1.1 Blood Banking ELISA
            • 13.1.1.2.2.1.2 Fluorescent Immunoassay (FIA)
            • 13.1.1.2.2.1.3 Latex Agglutination
            • 13.1.1.2.2.1.4 Turbidimetry
          • 13.1.1.2.2.2 Immunochromatography
          • 13.1.1.2.2.3 Cellular Analysis
          • 13.1.1.2.2.4 Sensor Technology
          • 13.1.1.2.2.5 Separation Technology
          • 13.1.1.2.2.6 Molecular Diagnosis
          • 13.1.1.2.2.7 Molecular Genomics
        • 13.1.1.2.3 Application
        • 13.1.1.2.4 Usability
        • 13.1.1.2.5 Site Of Testing
        • 13.1.1.2.6 Specimen
        • 13.1.1.2.7 By End User
    • 13.1.2 Saudi Arabia Market
      • 13.1.2.1 Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
      • 13.1.2.2 Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market- By Segmentation
        • 13.1.2.2.1 Product
          • 13.1.2.2.1.1 Instruments
            • 13.1.2.2.1.1.1 Clinical Chemistry Analyzers
            • 13.1.2.2.1.1.1.1 Automated Clinical Chemistry Analyzers
            • 13.1.2.2.1.1.2 Immunoassay Instruments
            • 13.1.2.2.1.1.2.1 ELISA Systems
            • 13.1.2.2.1.1.2.2 Fluorescent Immunoassay Analyzers
            • 13.1.2.2.1.1.3 Hematology And Coagulation Analyzers
            • 13.1.2.2.1.1.3.1 Blood Cell Morphology Analyzers
            • 13.1.2.2.1.1.3.2 ESR Analyzers
            • 13.1.2.2.1.1.3.3 Coagulation Analyzers
            • 13.1.2.2.1.1.4 Urinalysis Instruments
          • 13.1.2.2.1.2 Technology
            • 13.1.2.2.1.2.1 Immunoassay Or Immunochemistry
            • 13.1.2.2.1.2.1.1 Enzyme-linked Immunosorbent Assay (ELISA)
            • 13.1.2.2.1.2.1.2 Blood Banking ELISA
            • 13.1.2.2.1.2.1.3 Fluorescent Immunoassay (FIA)
            • 13.1.2.2.1.2.1.4 Latex Agglutination
            • 13.1.2.2.1.2.1.5 Turbidimetry
            • 13.1.2.2.1.2.2 Immunochromatography
            • 13.1.2.2.1.2.3 Cellular Analysis
            • 13.1.2.2.1.2.4 Sensor Technology
            • 13.1.2.2.1.2.5 Separation Technology
            • 13.1.2.2.1.2.6 Molecular Diagnosis
            • 13.1.2.2.1.2.7 Molecular Genomics
          • 13.1.2.2.1.3 Application
          • 13.1.2.2.1.4 Usability
          • 13.1.2.2.1.5 Site Of Testing
          • 13.1.2.2.1.6 Specimen
          • 13.1.2.2.1.7 By End User
    • 13.1.3 UAE Market
      • 13.1.3.1 UAE: Middle East and Africa In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
      • 13.1.3.2 UAE: Middle East and Africa In-Vitro Diagnostic Market- By Segmentation
        • 13.1.3.2.1 Product
          • 13.1.3.2.1.1 Instruments
            • 13.1.3.2.1.1.1 Clinical Chemistry Analyzers
            • 13.1.3.2.1.1.1.1 Automated Clinical Chemistry Analyzers
            • 13.1.3.2.1.1.2 Immunoassay Instruments
            • 13.1.3.2.1.1.2.1 ELISA Systems
            • 13.1.3.2.1.1.2.2 Fluorescent Immunoassay Analyzers
            • 13.1.3.2.1.1.3 Hematology And Coagulation Analyzers
            • 13.1.3.2.1.1.3.1 Blood Cell Morphology Analyzers
            • 13.1.3.2.1.1.3.2 ESR Analyzers
            • 13.1.3.2.1.1.3.3 Coagulation Analyzers
            • 13.1.3.2.1.1.4 Urinalysis Instruments
        • 13.1.3.2.2 Technology
          • 13.1.3.2.2.1 Immunoassay Or Immunochemistry
            • 13.1.3.2.2.1.1 Enzyme-linked Immunosorbent Assay (ELISA)
            • 13.1.3.2.2.1.1.1 Blood Banking ELISA
            • 13.1.3.2.2.1.2 Fluorescent Immunoassay (FIA)
            • 13.1.3.2.2.1.3 Latex Agglutination
            • 13.1.3.2.2.1.4 Turbidimetry
          • 13.1.3.2.2.2 Immunochromatography
          • 13.1.3.2.2.3 Cellular Analysis
          • 13.1.3.2.2.4 Sensor Technology
          • 13.1.3.2.2.5 Separation Technology
          • 13.1.3.2.2.6 Molecular Diagnosis
          • 13.1.3.2.2.7 Molecular Genomics
        • 13.1.3.2.3 Application
        • 13.1.3.2.4 Usability
        • 13.1.3.2.5 Site Of Testing
        • 13.1.3.2.6 Specimen
        • 13.1.3.2.7 By End User
    • 13.1.4 Rest of MEA Market
      • 13.1.4.1 Rest of MEA: Middle East and Africa In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
      • 13.1.4.2 Rest of MEA: Middle East and Africa In-Vitro Diagnostic Market- By Segmentation
        • 13.1.4.2.1 Product
          • 13.1.4.2.1.1 Instruments
            • 13.1.4.2.1.1.1 Clinical Chemistry Analyzers
            • 13.1.4.2.1.1.1.1 Automated Clinical Chemistry Analyzers
            • 13.1.4.2.1.1.2 Immunoassay Instruments
            • 13.1.4.2.1.1.2.1 ELISA Systems
            • 13.1.4.2.1.1.3 Fluorescent Immunoassay Analyzers
            • 13.1.4.2.1.1.4 Hematology And Coagulation Analyzers
            • 13.1.4.2.1.1.4.1 Blood Cell Morphology Analyzers
            • 13.1.4.2.1.1.4.2 ESR Analyzers
            • 13.1.4.2.1.1.4.3 Coagulation Analyzers
            • 13.1.4.2.1.1.5 Urinalysis Instruments
        • 13.1.4.2.2 Technology
          • 13.1.4.2.2.1 Immunoassay Or Immunochemistry
            • 13.1.4.2.2.1.1 Enzyme-linked Immunosorbent Assay (ELISA)
            • 13.1.4.2.2.1.1.1 Blood Banking ELISA
            • 13.1.4.2.2.1.2 Fluorescent Immunoassay (FIA)
            • 13.1.4.2.2.1.3 Latex Agglutination
            • 13.1.4.2.2.1.4 Turbidimetry
          • 13.1.4.2.2.2 Immunochromatography
          • 13.1.4.2.2.3 Cellular Analysis
          • 13.1.4.2.2.4 Sensor Technology
          • 13.1.4.2.2.5 Separation Technology
          • 13.1.4.2.2.6 Molecular Diagnosis
          • 13.1.4.2.2.7 Molecular Genomics
        • 13.1.4.2.3 Application
        • 13.1.4.2.4 Usability
        • 13.1.4.2.5 Site Of Testing
        • 13.1.4.2.6 Specimen
        • 13.1.4.2.7 By End User

14. Middle East and Africa In-Vitro Diagnostic Market Industry Landscape

  • 14.1 List of Key 20 Global Players
  • 14.2 List of Key 20 End Users in MEA In-Vitro Diagnostic Market

15. Middle East and Africa In-Vitro Diagnostic Market - Key Company Profiles

  • 15.1 Abbott
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 F. Hoffmann-La Roche Ltd
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Danaher Corp
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Siemens AG
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 Becton Dickinson and Co
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Sysmex Corp
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Bio-Rad Laboratories Inc
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 bioMerieux SA
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 DiaSorin SpA
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 QuidelOrtho Corp
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments
  • 15.11 ARKRAY Inc
    • 15.11.1 Key Facts
    • 15.11.2 Business Description
    • 15.11.3 Products and Services
    • 15.11.4 Financial Overview
    • 15.11.5 SWOT Analysis
    • 15.11.6 Key Developments
  • 15.12 BioSystems
    • 15.12.1 Key Facts
    • 15.12.2 Business Description
    • 15.12.3 Products and Services
    • 15.12.4 Financial Overview
    • 15.12.5 SWOT Analysis
    • 15.12.6 Key Developments
  • 15.13 Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • 15.13.1 Key Facts
    • 15.13.2 Business Description
    • 15.13.3 Products and Services
    • 15.13.4 Financial Overview
    • 15.13.5 SWOT Analysis
    • 15.13.6 Key Developments
  • 15.14 Werfen SA
    • 15.14.1 Key Facts
    • 15.14.2 Business Description
    • 15.14.3 Products and Services
    • 15.14.4 Financial Overview
    • 15.14.5 SWOT Analysis
    • 15.14.6 Key Developments
  • 15.15 Diagnostica Stago, Inc
    • 15.15.1 Key Facts
    • 15.15.2 Business Description
    • 15.15.3 Products and Services
    • 15.15.4 Financial Overview
    • 15.15.5 SWOT Analysis
    • 15.15.6 Key Developments

16. Appendix

  • 16.1 Glossary
  • 16.2 Research Methodology and Approach
    • 16.2.1 Secondary Research
    • 16.2.2 Primary Research
    • 16.2.3 Market Estimation Approach
      • 16.2.3.1 Supply Side Analysis
      • 16.2.3.2 Demand Side Analysis
    • 16.2.4 Research Assumptions and Limitations
    • 16.2.5 Currency Conversion
  • 16.2 About The Insight Partners
  • 16.2 Market Intelligence Cloud

List Of Figures

  • Table 1. Middle East and Africa In-Vitro Diagnostic Market Segmentation
  • Table 2. Import Analysis- China/Europe
  • Table 3. Export Analysis- China/Europe
  • Table 4. List of Regulatory Bodies and Organizations
  • Table 5. Prevalence of Key Disease Indications
  • Table 6. Manufacturing & Retail Pricing of Key 10 Brands
  • Table 7. List of Companies Operating Through Trade and Tenders
  • Table 8. Market Share Analysis, 2025 - By Key Players
  • Table 9. Market Share Analysis, 2024 - By Product Category (%)
  • Table 10. Market Share Analysis, 2024 - By Product Category (%)
  • Table 11. Market Share Analysis, 2024 - By Product Brands (%)
  • Table 12. Market Share Analysis, 2024 - By Product Brands (%)
  • Table 13. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million)
  • Table 14. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million)
  • Table 15. List of Key Players in Product Market, (US$)
  • Table 16. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 17. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 18. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 19. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 20. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Automated Clinical Chemistry Analyzers
  • Table 21. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Automated Clinical Chemistry Analyzers
  • Table 22. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 23. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 24. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by ELISA Systems
  • Table 25. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by ELISA Systems
  • Table 26. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Fluorescent Immunoassay Analyzers
  • Table 27. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Fluorescent Immunoassay Analyzers
  • Table 28. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Hematology And Coagulation Analyzers
  • Table 29. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Hematology And Coagulation Analyzers
  • Table 30. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Blood Cell Morphology Analyzers
  • Table 31. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Blood Cell Morphology Analyzers
  • Table 32. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by ESR Analyzers
  • Table 33. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by ESR Analyzers
  • Table 34. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Coagulation Analyzers
  • Table 35. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Coagulation Analyzers
  • Table 36. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Urinalysis Instruments
  • Table 37. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by ESR Analyzers
  • Table 38. List of Key Players in Technology Market, (US$)
  • Table 39. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Immunoassay or Immunochemistry
  • Table 40. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Immunoassay or Immunochemistry
  • Table 41. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Enzyme-linked Immunosorbent Assay (ELISA)
  • Table 42. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Enzyme-linked Immunosorbent Assay (ELISA)
  • Table 43. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Blood Banking ELISA
  • Table 44. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Blood Banking ELISA
  • Table 45. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Fluorescent Immunoassay (FIA)
  • Table 46. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Fluorescent Immunoassay (FIA)
  • Table 47. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Latex Agglutination
  • Table 48. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Latex Agglutination
  • Table 49. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Turbidimetry
  • Table 50. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Turbidimetry
  • Table 51. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Immunochromatography
  • Table 52. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Immunochromatography
  • Table 53. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Cellular Analysis
  • Table 54. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Cellular Analysis
  • Table 55. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Sensor Technology
  • Table 56. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Sensor Technology
  • Table 57. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Separation Technology
  • Table 58. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Separation Technology
  • Table 59. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Molecular Diagnosis
  • Table 60. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Molecular Genomics
  • Table 61. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025(US$ Million) - by Molecular Genomics
  • Table 62. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034(US$ Million) - by Molecular Genomics
  • Table 63. List of Key Players in Application Market, (US$)
  • Table 64. List of Key Players in Usability Market, (US$)
  • Table 65. List of Key Players in Site of Testing Market, (US$)
  • Table 66. List of Key Players in Specimen Market, (US$)
  • Table 67. List of Key Players in End User Market, (US$)
  • Table 68. Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 69. Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 70. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 71. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 72. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 73. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 74. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 75. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 76. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Automated Clinical Chemistry Analyzers
  • Table 77. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Automated Clinical Chemistry Analyzers
  • Table 78. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 79. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 80. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by ELISA Systems
  • Table 81. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by ELISA Systems
  • Table 82. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Fluorescent Immunoassay Analyzers
  • Table 83. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Fluorescent Immunoassay Analyzers
  • Table 84. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Hematology And Coagulation Analyzers
  • Table 85. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Hematology And Coagulation Analyzers
  • Table 86. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Blood Cell Morphology Analyzers
  • Table 87. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Blood Cell Morphology Analyzers
  • Table 88. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by ESR Analyzers
  • Table 89. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by ESR Analyzers
  • Table 90. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Coagulation Analyzers
  • Table 91. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Coagulation Analyzers
  • Table 92. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 93. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 94. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 95. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 96. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 97. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 98. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Enzyme-linked Immunosorbent Assay (ELISA)
  • Table 99. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Enzyme-linked Immunosorbent Assay (ELISA)
  • Table 100. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Blood Banking ELISA
  • Table 101. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Blood Banking ELISA
  • Table 102. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Fluorescent Immunoassay (FIA)
  • Table 103. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Fluorescent Immunoassay (FIA)
  • Table 104. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Latex Agglutination
  • Table 105. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Latex Agglutination
  • Table 106. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Turbidimetry
  • Table 107. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Turbidimetry
  • Table 108. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 109. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 110. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 111. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 112. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 113. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 114. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 115. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 116. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 117. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 118. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 119. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 120. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 121. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 122. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 123. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 124. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 125. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 126. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 127. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 128. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 129. South Africa: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 130. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 131. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 132. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 133. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 134. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 135. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 136. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Automated Clinical Chemistry Analyzers
  • Table 137. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Automated Clinical Chemistry Analyzers
  • Table 138. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 139. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 140. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by ELISA Systems
  • Table 141. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by ELISA Systems
  • Table 142. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Fluorescent Immunoassay Analyzers
  • Table 143. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Fluorescent Immunoassay Analyzers
  • Table 144. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Hematology And Coagulation Analyzers
  • Table 145. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Hematology And Coagulation Analyzers
  • Table 146. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Blood Cell Morphology Analyzers
  • Table 147. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Blood Cell Morphology Analyzers
  • Table 148. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by ESR Analyzers
  • Table 149. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by ESR Analyzers
  • Table 150. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Coagulation Analyzers
  • Table 151. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Coagulation Analyzers
  • Table 152. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 153. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 154. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 155. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 156. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 157. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 158. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Enzyme-linked Immunosorbent Assay (ELISA)
  • Table 159. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Enzyme-linked Immunosorbent Assay (ELISA)
  • Table 160. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Blood Banking ELISA
  • Table 161. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Blood Banking ELISA
  • Table 162. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Fluorescent Immunoassay (FIA)
  • Table 163. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Fluorescent Immunoassay (FIA)
  • Table 164. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Latex Agglutination
  • Table 165. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Latex Agglutination
  • Table 166. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Turbidimetry
  • Table 167. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Turbidimetry
  • Table 168. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 169. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 170. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 171. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 172. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 173. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 174. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 175. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 176. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 177. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 178. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 179. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 180. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 181. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 182. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 183. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 184. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 185. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 186. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 187. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 188. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 189. Saudi Arabia: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 190. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 191. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 192. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 193. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 194. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 195. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 196. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Automated Clinical Chemistry Analyzers
  • Table 197. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Automated Clinical Chemistry Analyzers
  • Table 198. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 199. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 200. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by ELISA Systems
  • Table 201. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by ELISA Systems
  • Table 202. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Fluorescent Immunoassay Analyzers
  • Table 203. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Fluorescent Immunoassay Analyzers
  • Table 204. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Hematology And Coagulation Analyzers
  • Table 205. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Hematology And Coagulation Analyzers
  • Table 206. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Blood Cell Morphology Analyzers
  • Table 207. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Blood Cell Morphology Analyzers
  • Table 208. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by ESR Analyzers
  • Table 209. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by ESR Analyzers
  • Table 210. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Coagulation Analyzers
  • Table 211. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Coagulation Analyzers
  • Table 212. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 213. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 214. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 215. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 216. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 217. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 218. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Enzyme-linked Immunosorbent Assay (ELISA)
  • Table 219. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Enzyme-linked Immunosorbent Assay (ELISA)
  • Table 220. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Blood Banking ELISA
  • Table 221. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Blood Banking ELISA
  • Table 222. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Fluorescent Immunoassay (FIA)
  • Table 223. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Fluorescent Immunoassay (FIA)
  • Table 224. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Latex Agglutination
  • Table 225. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Latex Agglutination
  • Table 226. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Turbidimetry
  • Table 227. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Turbidimetry
  • Table 228. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 229. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 230. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 231. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 232. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 233. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 234. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 235. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 236. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 237. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 238. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 239. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 240. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 241. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 242. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 243. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 244. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 245. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 246. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 247. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 248. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 249. UAE: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 250. Rest of MEA: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 251. REST OF MEA: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 252. Rest of MEA: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 253. Rest Of MEA: Middle East and Africa In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 254. Rest Of MEA: Middle East and Africa In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 255.